Literature DB >> 5818715

Amantadine in the treatment of Parkinson's disease.

R S Schwab, A C England, D C Poskanzer, R R Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5818715

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  124 in total

1.  Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.

Authors:  J Iwahashi; K Tsuji; T Ishibashi; J Kajiwara; Y Imamura; R Mori; K Hara; T Kashiwagi; Y Ohtsu; N Hamada; H Maeda; M Toyoda; T Toyoda
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 2.  Pharmacological treatment of Parkinson's disease.

Authors:  A Münchau; K P Bhatia
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  On the synchronizing effect of amantadine-1-hydrochlorid (Symmetrel) on pathological EEG-activity.

Authors:  J Vardi; M Streifler
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

4.  Parkinson and his disease revisited.

Authors:  D G James; R Hierons
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

5.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

Review 6.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 7.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

8.  Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations.

Authors:  M Brenner; A Haass; P Jacobi; K Schimrigk
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

9.  Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa.

Authors:  L Rivera-Calimlim
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

Review 10.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.